Morgan Stanley’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,512,380
Closed -$658K 7901
2022
Q4
$658K Buy
1,512,380
+1,500,000
+12,116% +$653K ﹤0.01% 5095
2022
Q3
$4K Sell
12,380
-1
-0% ﹤0.01% 7354
2022
Q2
$4K Sell
12,381
-4,873
-28% -$1.57K ﹤0.01% 7485
2022
Q1
$12K Sell
17,254
-842
-5% -$586 ﹤0.01% 7363
2021
Q4
$24K Sell
18,096
-50,287
-74% -$66.7K ﹤0.01% 7151
2021
Q3
$149K Buy
68,383
+39,471
+137% +$86K ﹤0.01% 6149
2021
Q2
$79K Sell
28,912
-28,406
-50% -$77.6K ﹤0.01% 6457
2021
Q1
$150K Sell
57,318
-296,568
-84% -$776K ﹤0.01% 5812
2020
Q4
$983K Buy
353,886
+349,556
+8,073% +$971K ﹤0.01% 4681
2020
Q3
$20K Buy
4,330
+1,330
+44% +$6.14K ﹤0.01% 6076
2020
Q2
$8K Buy
3,000
+2,151
+253% +$5.74K ﹤0.01% 6227
2020
Q1
$2K Sell
849
-1,842
-68% -$4.34K ﹤0.01% 6422
2019
Q4
$13K Sell
2,691
-2,083
-44% -$10.1K ﹤0.01% 6206
2019
Q3
$30K Buy
4,774
+4,425
+1,268% +$27.8K ﹤0.01% 5899
2019
Q2
$2K Sell
349
-27,038
-99% -$155K ﹤0.01% 6489
2019
Q1
$291K Buy
27,387
+23,874
+680% +$254K ﹤0.01% 4864
2018
Q4
$29K Buy
3,513
+722
+26% +$5.96K ﹤0.01% 5939
2018
Q3
$54K Sell
2,791
-37,465
-93% -$725K ﹤0.01% 5863
2018
Q2
$727K Buy
40,256
+30,843
+328% +$557K ﹤0.01% 4841
2018
Q1
$100K Sell
9,413
-115,353
-92% -$1.23M ﹤0.01% 5708
2017
Q4
$5.26M Buy
124,766
+108,782
+681% +$4.59M ﹤0.01% 3063
2017
Q3
$879K Buy
15,984
+4,222
+36% +$232K ﹤0.01% 4515
2017
Q2
$2.18M Buy
11,762
+2,840
+32% +$527K ﹤0.01% 3720
2017
Q1
$1.07M Sell
8,922
-4,929
-36% -$589K ﹤0.01% 4338
2016
Q4
$1.38M Buy
13,851
+8,347
+152% +$829K ﹤0.01% 4219
2016
Q3
$616K Buy
5,504
+4,459
+427% +$499K ﹤0.01% 4397
2016
Q2
$107K Sell
1,045
-739
-41% -$75.7K ﹤0.01% 5214
2016
Q1
$163K Sell
1,784
-2,070
-54% -$189K ﹤0.01% 5090
2015
Q4
$556K Buy
3,854
+3,344
+656% +$482K ﹤0.01% 4473
2015
Q3
$53K Sell
510
-21,898
-98% -$2.28M ﹤0.01% 5704
2015
Q2
$3.65M Buy
+22,408
New +$3.65M ﹤0.01% 3074